Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs052230195Completed
Randomised trial of remifentanil in hysterectomy (3 arms), sponsored by Nara Medical University. Primary endpoint: Intraoperative remifentanil usage normalized by time and ideal body weight. Started Mar 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs052230195.